The second sub-component of the Virtuoso System to reach “design freeze” is the Surgeon Workstation. Having the sub-component meet design freeze means that it is ready for final fabrication, testing, and submission to the Food & Drug Administration for approval. The remaining two sub-components of the system, the Endoscope/Motorpack and the System Holding Arm, are expected to reach their design-freeze milestones by the end of 2022.
Virtuoso System Completes Central-Airway Cadaver Experiments
Virtuoso Surgical received funding from the National Institutes of Health to conduct experiments using the Virtuoso System to approach lesions, including cancerous blockages, of the trachea. The final experiments were a success, demonstrating clear benefits of the Virtuoso System for removing cancerous blockages from the trachea.
Virtuoso System Meets First “Design Freeze” Milestone
The Virtuoso System has four main sub-components: the Surgeon Input Device, the Surgeon Workstation, the Endoscope/Motorpack, and the System Holding Arm. The first sub-component to reach “design freeze” is the Surgeon Input Device. Having the sub-component meet design freeze means that it is ready for final fabrication, testing, and submission to the Food & Drug Administration for approval. The remaining three sub-components are expected to reach their design-freeze milestones by the end of 2022.